AC Immune Ltd Capital Reinvestment Ratio
AC Immune Ltd capital reinvestment ratio. AC Immune Ltd (ACIU) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.93 Million) in capital expenditures ($90.00K). Check ACIU capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AC Immune Ltd (2015–2024)
Capital reinvestment ratio of AC Immune Ltd from 2015 to 2024. This chart tracks AC Immune Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore AC Immune Ltd (ACIU) net asset momentum to track the company's year-over-year net asset growth rate.
AC Immune Ltd Capital Reinvestment Ratio by Year (2015–2024)
AC Immune Ltd capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see ACIU cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $65.84 Million | $576.00K | ▼ -74.4% |
| 2019 | 0.03x | $55.22 Million | $1.89 Million | ▲ +516.7% |
| 2015 | 0.01x | $44.08 Million | $244.00K | — |